Purchase Of Antiretroviral Drugs Parts 1 3 Part 3 Lamivudine 300Mg Tablet 30

Deadline: 05 Feb 2026

Poland

Ref. No.: 21985437

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Purchase Of Antiretroviral Drugs Parts 1 3 Part 2 Lamivudine 150Mg Tablet 60

Deadline: 05 Feb 2026

Poland

Ref. No.: 21985435

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Purchase Of Antiretroviral Drugs Parts 1 3 Part 1 Cabotegravir 30Mg Tablet 30

Deadline: 05 Feb 2026

Poland

Ref. No.: 21985422

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21984326

EMD:Ref Document

Bid Value: Ref Document

330 Days Left

Purchase Of Antiretroviral Drugs Parts 1 3 Part 3 Darunavir 800Mg Tablet 30

Deadline: 05 Feb 2026

Poland

Ref. No.: 21983288

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Purchase Of Antiretroviral Drugs Parts 1 3 Part 2 Abacavir Lamivudine 600 300Mg Tablet 30

Deadline: 05 Feb 2026

Poland

Ref. No.: 21983282

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Purchase Of Antiretroviral Drugs Parts 1 3 Part 1 Abacavir Lamivudine 600 300Mg Tablet 30

Deadline: 05 Feb 2026

Poland

Ref. No.: 21983281

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pazopanib

Deadline: 10 May 2027

Germany

Ref. No.: 21963425

EMD:Ref Document

Bid Value: Ref Document

460 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V I In Accordance With Section 31 Paragraph 1 Sgb V About Blood Sugar Test Strips For The Period 01 01 26 31 12 27 Plus V Option 1 X 24 Months

Deadline: 03 Nov 2029

Germany

Ref. No.: 21962064

EMD:Ref Document

Bid Value: Ref Document

1368 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pazopanib

Deadline: 10 May 2027

Germany

Ref. No.: 21953401

EMD:Ref Document

Bid Value: Ref Document

460 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V From December 1St 2025

Deadline: 10 Nov 2027

Germany

Ref. No.: 21941798

EMD:Ref Document

Bid Value: Ref Document

644 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21914423

EMD:Ref Document

Bid Value: Ref Document

330 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21913923

EMD:Ref Document

Bid Value: Ref Document

330 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Lactulose Atc Code According To Who A06Ad11

Deadline: 31 Dec 2027

Germany

Ref. No.: 21913052

EMD:Ref Document

Bid Value: Ref Document

695 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Colistin Atc Code According To Who J01Xb01

Deadline: 31 Dec 2027

Germany

Ref. No.: 21912741

EMD:Ref Document

Bid Value: Ref Document

695 Days Left

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!